Stryker Free Cash Flow vs Begin Period Cash Flow Analysis

SYK Stock

USD 388.14 1.57 0.40%

Stryker financial indicator trend analysis is much more than just breaking down Stryker prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Stryker is a good investment. Please check the relationship between Stryker Free Cash Flow and its Begin Period Cash Flow accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.

Free Cash Flow vs Begin Period Cash Flow

Free Cash Flow vs Begin Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Stryker Free Cash Flow account and Begin Period Cash Flow. At this time, the significance of the direction appears to have very week relationship.

The correlation between Stryker's Free Cash Flow and Begin Period Cash Flow is 0.29. Overlapping area represents the amount of variation of Free Cash Flow that can explain the historical movement of Begin Period Cash Flow in the same time period over historical financial statements of Stryker, assuming nothing else is changed. The correlation between historical values of Stryker's Free Cash Flow and Begin Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow of Stryker are associated (or correlated) with its Begin Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Begin Period Cash Flow has no effect on the direction of Free Cash Flow i.e., Stryker's Free Cash Flow and Begin Period Cash Flow go up and down completely randomly.

Correlation Coefficient

0.29

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Most indicators from Stryker's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Stryker current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.At this time, Stryker's Selling General Administrative is quite stable compared to the past year. Enterprise Value is expected to rise to about 116.9 B this year, although the value of Tax Provision will most likely fall to about 289.7 M.

	2021	2022	2023	2024 (projected)
Gross Profit	11.0B	11.6B	13.1B	13.8B
Total Revenue	17.1B	18.4B	20.5B	21.5B

Gross Profit Total Revenue

Stryker fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Property Plant And Equipment Gross	Short Term Investments	Current Deferred Revenue
Total Assets		0.97	0.94	0.94	0.97	0.99	0.94	0.98	0.65	0.99	0.93	-0.01	0.99	0.63	0.95	0.98	0.09	0.97	0.99	0.87	0.74	0.95	0.94	0.91	-0.5	0.76
Short Long Term Debt Total	0.97		0.87	0.86	0.89	0.98	0.96	0.91	0.68	0.99	0.91	-0.11	0.93	0.46	0.99	0.95	-0.07	0.89	0.99	0.75	0.68	0.98	0.88	0.86	-0.66	0.78
Other Current Liab	0.94	0.87		0.92	0.92	0.9	0.82	0.93	0.67	0.89	0.83	0.22	0.91	0.68	0.86	0.89	0.23	0.95	0.92	0.92	0.69	0.88	0.83	0.79	-0.3	0.63
Total Current Liabilities	0.94	0.86	0.92		0.94	0.91	0.85	0.95	0.54	0.91	0.9	-0.01	0.93	0.67	0.81	0.96	0.18	0.92	0.9	0.87	0.89	0.81	0.93	0.89	-0.37	0.7
Total Stockholder Equity	0.97	0.89	0.92	0.94		0.96	0.88	1.0	0.59	0.94	0.9	0.05	0.99	0.73	0.87	0.97	0.21	0.98	0.93	0.92	0.76	0.87	0.95	0.92	-0.37	0.69
Property Plant And Equipment Net	0.99	0.98	0.9	0.91	0.96		0.95	0.97	0.67	0.99	0.94	-0.06	0.98	0.58	0.97	0.98	0.01	0.95	0.99	0.84	0.73	0.96	0.92	0.9	-0.58	0.76
Net Debt	0.94	0.96	0.82	0.85	0.88	0.95		0.89	0.46	0.98	0.88	-0.28	0.91	0.43	0.95	0.92	-0.02	0.84	0.96	0.67	0.64	0.92	0.92	0.91	-0.6	0.85
Retained Earnings	0.98	0.91	0.93	0.95	1.0	0.97	0.89		0.63	0.96	0.91	0.04	0.99	0.71	0.89	0.98	0.16	0.98	0.95	0.91	0.76	0.9	0.95	0.92	-0.41	0.7
Cash	0.65	0.68	0.67	0.54	0.59	0.67	0.46	0.63		0.61	0.62	0.37	0.64	0.42	0.69	0.63	-0.21	0.68	0.68	0.68	0.48	0.71	0.44	0.4	-0.52	0.24
Non Current Assets Total	0.99	0.99	0.89	0.91	0.94	0.99	0.98	0.96	0.61		0.94	-0.14	0.96	0.54	0.97	0.98	-0.01	0.93	0.99	0.79	0.72	0.96	0.94	0.92	-0.6	0.79
Non Currrent Assets Other	0.93	0.91	0.83	0.9	0.9	0.94	0.88	0.91	0.62	0.94		-0.11	0.9	0.53	0.88	0.93	-0.03	0.88	0.92	0.76	0.8	0.88	0.9	0.88	-0.58	0.65
Cash And Short Term Investments	-0.01	-0.11	0.22	-0.01	0.05	-0.06	-0.28	0.04	0.37	-0.14	-0.11		0.0	0.27	-0.06	-0.09	0.52	0.15	-0.05	0.42	-0.14	0.0	-0.23	-0.28	0.55	-0.25
Net Receivables	0.99	0.93	0.91	0.93	0.99	0.98	0.91	0.99	0.64	0.96	0.9	0.0		0.67	0.91	0.99	0.14	0.98	0.96	0.89	0.76	0.91	0.95	0.92	-0.47	0.72
Common Stock Shares Outstanding	0.63	0.46	0.68	0.67	0.73	0.58	0.43	0.71	0.42	0.54	0.53	0.27	0.67		0.45	0.64	0.3	0.74	0.54	0.81	0.54	0.49	0.59	0.54	0.09	0.27
Non Current Liabilities Total	0.95	0.99	0.86	0.81	0.87	0.97	0.95	0.89	0.69	0.97	0.88	-0.06	0.91	0.45		0.91	-0.07	0.88	0.98	0.75	0.59	0.99	0.83	0.82	-0.64	0.77
Inventory	0.98	0.95	0.89	0.96	0.97	0.98	0.92	0.98	0.63	0.98	0.93	-0.09	0.99	0.64	0.91		0.03	0.95	0.97	0.85	0.83	0.91	0.95	0.92	-0.53	0.74
Other Current Assets	0.09	-0.07	0.23	0.18	0.21	0.01	-0.02	0.16	-0.21	-0.01	-0.03	0.52	0.14	0.3	-0.07	0.03		0.2	0.0	0.37	0.0	-0.02	0.09	0.05	0.67	0.06
Other Stockholder Equity	0.97	0.89	0.95	0.92	0.98	0.95	0.84	0.98	0.68	0.93	0.88	0.15	0.98	0.74	0.88	0.95	0.2		0.93	0.93	0.72	0.9	0.9	0.86	-0.37	0.6
Total Liab	0.99	0.99	0.92	0.9	0.93	0.99	0.96	0.95	0.68	0.99	0.92	-0.05	0.96	0.54	0.98	0.97	0.0	0.93		0.82	0.71	0.97	0.9	0.88	-0.58	0.78
Total Current Assets	0.87	0.75	0.92	0.87	0.92	0.84	0.67	0.91	0.68	0.79	0.76	0.42	0.89	0.81	0.75	0.85	0.37	0.93	0.82		0.68	0.77	0.76	0.71	-0.11	0.54
Short Term Debt	0.74	0.68	0.69	0.89	0.76	0.73	0.64	0.76	0.48	0.72	0.8	-0.14	0.76	0.54	0.59	0.83	0.0	0.72	0.71	0.68		0.59	0.78	0.73	-0.43	0.48
Intangible Assets	0.95	0.98	0.88	0.81	0.87	0.96	0.92	0.9	0.71	0.96	0.88	0.0	0.91	0.49	0.99	0.91	-0.02	0.9	0.97	0.77	0.59		0.81	0.79	-0.6	0.7
Accounts Payable	0.94	0.88	0.83	0.93	0.95	0.92	0.92	0.95	0.44	0.94	0.9	-0.23	0.95	0.59	0.83	0.95	0.09	0.9	0.9	0.76	0.78	0.81		0.99	-0.5	0.76
Property Plant And Equipment Gross	0.91	0.86	0.79	0.89	0.92	0.9	0.91	0.92	0.4	0.92	0.88	-0.28	0.92	0.54	0.82	0.92	0.05	0.86	0.88	0.71	0.73	0.79	0.99		-0.51	0.77
Short Term Investments	-0.5	-0.66	-0.3	-0.37	-0.37	-0.58	-0.6	-0.41	-0.52	-0.6	-0.58	0.55	-0.47	0.09	-0.64	-0.53	0.67	-0.37	-0.58	-0.11	-0.43	-0.6	-0.5	-0.51		-0.4
Current Deferred Revenue	0.76	0.78	0.63	0.7	0.69	0.76	0.85	0.7	0.24	0.79	0.65	-0.25	0.72	0.27	0.77	0.74	0.06	0.6	0.78	0.54	0.48	0.7	0.76	0.77	-0.4

Click cells to compare fundamentals

Stryker Account Relationship Matchups

Stryker fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	30.2B	34.3B	34.6B	36.9B	39.9B	41.9B
Short Long Term Debt Total	11.1B	14.0B	12.5B	13.0B	13.0B	13.6B
Other Current Liab	2.9B	3.5B	3.4B	3.3B	3.8B	4.0B
Total Current Liabilities	4.4B	5.0B	4.5B	6.3B	7.9B	8.3B
Total Stockholder Equity	12.8B	13.1B	14.9B	16.6B	18.6B	19.5B
Property Plant And Equipment Net	2.6B	2.8B	2.8B	3.0B	3.2B	3.4B
Net Debt	5.9B	10.3B	9.5B	11.2B	10.0B	10.5B
Retained Earnings	11.7B	12.5B	13.5B	14.8B	16.8B	17.6B
Cash	4.3B	2.9B	2.9B	1.8B	3.0B	3.1B
Non Current Assets Total	18.8B	24.6B	24.6B	26.6B	27.4B	28.8B
Non Currrent Assets Other	1.4B	2.0B	2.2B	2.4B	2.7B	2.8B
Cash And Short Term Investments	4.4B	3.0B	3.0B	1.9B	3.1B	1.7B
Net Receivables	2.9B	2.7B	3.0B	3.6B	3.8B	4.0B
Liabilities And Stockholders Equity	30.2B	34.3B	34.6B	36.9B	39.9B	41.9B
Non Current Liabilities Total	13.0B	16.2B	15.2B	14.0B	13.4B	14.1B
Inventory	3.3B	3.5B	3.3B	4.0B	4.8B	5.1B
Other Current Assets	760M	488M	662M	1.5B	857M	542.0M
Other Stockholder Equity	1.6B	1.7B	1.9B	2.0B	2.2B	2.3B
Total Liab	17.4B	21.2B	19.8B	20.3B	21.3B	22.4B
Total Current Assets	11.4B	9.7B	10.0B	10.3B	12.5B	13.1B
Short Term Debt	859M	761M	7M	1.3B	2.2B	2.3B
Intangible Assets	4.2B	5.6B	4.8B	4.9B	4.6B	4.8B
Accounts Payable	675M	810M	1.1B	1.4B	1.5B	1.6B
Property Plant And Equipment Gross	2.6B	2.8B	5.5B	5.8B	6.3B	6.7B
Accumulated Other Comprehensive Income	(606M)	(1.2B)	(531M)	(221M)	(416M)	(395.2M)
Short Term Investments	88M	81M	75M	84M	82M	77.9M
Good Will	9.1B	12.8B	12.9B	14.9B	15.2B	16.0B
Other Liab	2.4B	3.0B	2.7B	1.8B	2.0B	1.1B
Other Assets	2.6B	3.5B	4.0B	3.9B	4.5B	4.7B
Long Term Debt	10.2B	13.2B	12.5B	11.9B	10.9B	11.4B
Property Plant Equipment	2.6B	2.8B	2.8B	3.0B	3.4B	3.6B
Net Tangible Assets	(489M)	(5.2B)	(2.9B)	(3.1B)	(2.8B)	(2.7B)
Retained Earnings Total Equity	11.7B	12.5B	13.5B	14.8B	17.0B	10.2B
Capital Surpluse	1.6B	1.7B	1.9B	2.0B	2.3B	1.5B
Non Current Liabilities Other	2.7B	3.0B	1.8B	1.5B	1.9B	1.8B
Accumulated Depreciation	(2.1B)	(2.4B)	(2.7B)	(2.8B)	(2.6B)	(2.7B)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Stryker is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Stryker Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Stryker Stock. Highlighted below are key reports to facilitate an investment decision about Stryker Stock:

How To Invest In Stryker

Details

Is Stryker Stock a good investment?

Details

What is Stryker's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.

You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stryker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.2

Dividend Share

3.2

Earnings Share

9.32

Revenue Per Share

57.728

Quarterly Revenue Growth

0.119

The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stryker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Stryker Free Cash Flow vs Begin Period Cash Flow Analysis

Free Cash Flow vs Begin Period Cash Flow

Free Cash Flow vs Begin Period Cash Flow Correlation Analysis

Correlation Coefficient

Free Cash Flow

Begin Period Cash Flow

Stryker fundamental ratios Correlations

Stryker Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Stryker fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Retained Earnings	+ 1.0	Total Stockholder Equity
Property Plant And Equipment Net	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Total Assets
Net Receivables	+ 0.99	Total Assets
Total Liab	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Short Long Term Debt Total

Short Term Investments	- 0.66	Short Long Term Debt Total
Short Term Investments	- 0.64	Non Current Liabilities Total
Short Term Investments	- 0.6	Intangible Assets
Short Term Investments	- 0.6	Non Current Assets Total
Short Term Investments	- 0.6	Net Debt
Short Term Investments	- 0.58	Total Liab